Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 2c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.57), $0.02 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance